[ Price : $8.95]
Public Citizen urges the Federal Trade Commission to investigate cardiovascular disease screening company HealthFairs direct-to-co...[ Price : $8.95]
FDA grants Halozyme Therapeutics a fast track designation for Halozymes PEGPH20 (PEGylated recombinant human hyaluronidase) in com...[ Price : $8.95]
The governors from five New England states urge HHS to rescind FDAs approval of Zogenix Zohydro ER (hydrocodone) because it does n...[ Price : $8.95]
Stericycle says that in the second quarter of this year, FDA had the fewest recalls of drugs, medical devices, and food tracked in...[ Price : $8.95]
CDER issues a MAPP with drug shortage management procedures.[ Price : $8.95]
FDA says it expects to implement in the first quarter of 2015 its eCTD Module 1 update.[ Price : $8.95]
Hyman, Phelps & McNamara asks FDA to require specific labeling statements and risk mitigation activities for any approval of Baxte...[ Price : $8.95]
FDA grants Acadia Pharmaceuticals a breakthrough therapy designation for Nuplazid (pimavanserin) for treating Parkinsons disease p...